These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 19183784)

  • 1. Augmentation treatment in major depressive disorder: focus on aripiprazole.
    Nelson JC; Pikalov A; Berman RM
    Neuropsychiatr Dis Treat; 2008 Oct; 4(5):937-48. PubMed ID: 19183784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants.
    Berman RM; Fava M; Thase ME; Trivedi MH; Swanink R; McQuade RD; Carson WH; Adson D; Taylor L; Hazel J; Marcus RN
    CNS Spectr; 2009 Apr; 14(4):197-206. PubMed ID: 19407731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Summary of the comparative effectiveness review on off-label use of atypical antipsychotics.
    Maher AR; Theodore G
    J Manag Care Pharm; 2012 Jun; 18(5 Suppl B):S1-20. PubMed ID: 22784311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second-generation antipsychotics for major depressive disorder and dysthymia.
    Komossa K; Depping AM; Gaudchau A; Kissling W; Leucht S
    Cochrane Database Syst Rev; 2010 Dec; (12):CD008121. PubMed ID: 21154393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examining the efficacy of adjunctive aripiprazole in major depressive disorder: a pooled analysis of 2 studies.
    Thase ME; Trivedi MH; Nelson JC; Fava M; Swanink R; Tran QV; Pikalov A; Yang H; Carlson BX; Marcus RN; Berman RM
    Prim Care Companion J Clin Psychiatry; 2008; 10(6):440-7. PubMed ID: 19287552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost-effectiveness of aripiprazole as adjunctive therapy in major depressive disorder: Thai economic model.
    Leelahanaj T
    J Med Assoc Thai; 2010 Nov; 93 Suppl 6():S43-50. PubMed ID: 21284136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of symptom severity on efficacy and safety of aripiprazole adjunctive to antidepressant monotherapy in major depressive disorder: a pooled analysis.
    Stewart TD; Hatch A; Largay K; Sheehan JJ; Marler SV; Berman RM; Nelson JC
    J Affect Disord; 2014 Jun; 162():20-5. PubMed ID: 24766999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effects of adjunctive aripiprazole in major depressive disorder are not dependent on antidepressant therapy history: a post hoc analysis of 3 randomized, double-blind, placebo-controlled trials.
    Dunner DL; Laubmeier KK; Manos G; Forbes RA; Baker RA; Berman RM
    Prim Care Companion CNS Disord; 2012; 14(6):. PubMed ID: 23585997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second-generation antipsychotics in the treatment of major depressive disorder: current evidence.
    Han C; Wang SM; Kato M; Lee SJ; Patkar AA; Masand PS; Pae CU
    Expert Rev Neurother; 2013 Jul; 13(7):851-70. PubMed ID: 23898855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmentation of antidepressants with atypical antipsychotic medications for treatment-resistant major depressive disorder: a meta-analysis.
    Papakostas GI; Shelton RC; Smith J; Fava M
    J Clin Psychiatry; 2007 Jun; 68(6):826-31. PubMed ID: 17592905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study.
    Marcus RN; McQuade RD; Carson WH; Hennicken D; Fava M; Simon JS; Trivedi MH; Thase ME; Berman RM
    J Clin Psychopharmacol; 2008 Apr; 28(2):156-65. PubMed ID: 18344725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjunctive aripiprazole in major depressive disorder: analysis of efficacy and safety in patients with anxious and atypical features.
    Trivedi MH; Thase ME; Fava M; Nelson CJ; Yang H; Qi Y; Tran QV; Pikalov A; Carlson BX; Marcus RN; Berman RM
    J Clin Psychiatry; 2008 Dec; 69(12):1928-36. PubMed ID: 19192475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Choice of Either Quetiapine or Aripiprazole as Augmentation Treatment in a European Naturalistic Sample of Patients With Major Depressive Disorder.
    Bartova L; Fugger G; Dold M; Kautzky A; Swoboda MMM; Rujescu D; Zohar J; Souery D; Mendlewicz J; Montgomery S; Fabbri C; Serretti A; Kasper S
    Int J Neuropsychopharmacol; 2022 Feb; 25(2):118-127. PubMed ID: 34637516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aripiprazole augmentation to antidepressant therapy in Japanese patients with major depressive disorder: a randomized, double-blind, placebo-controlled study (ADMIRE study).
    Kamijima K; Higuchi T; Ishigooka J; Ohmori T; Ozaki N; Kanba S; Kinoshita T; Koyama T;
    J Affect Disord; 2013 Dec; 151(3):899-905. PubMed ID: 24074484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of aripiprazole as adjunctive therapy in major depressive disorder with somatic symptoms: A randomized, double-blind, placebo-controlled trial with clinical and electroencephalography evidence.
    Kim HJ; Han DH; Choi KT; Hwang HC; Min KJ; Kim SM
    J Psychopharmacol; 2023 Mar; 37(3):289-302. PubMed ID: 36239033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repetitive transcranial magnetic stimulation for the treatment of major depressive disorder: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2004; 4(7):1-98. PubMed ID: 23074457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Augmentation with atypical antipsychotics for depression: a review of evidence-based support from the medical literature.
    Wright BM; Eiland EH; Lorenz R
    Pharmacotherapy; 2013 Mar; 33(3):344-59. PubMed ID: 23456734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-Effectiveness Analysis of Aripiprazole Augmentation Treatment of Patients with Major Depressive Disorder Compared to Olanzapine and Quetiapine Augmentation in Turkey: A Microsimulation Approach.
    Saylan M; Treur MJ; Postema R; Dilbaz N; Savas H; Heeg BM; Drost PB
    Value Health Reg Issues; 2013; 2(2):171-180. PubMed ID: 29702862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.